Related by context. Frequent words. (Click for all words.) 79 Onalta 78 liposomal formulation 76 Panzem R 76 Factor VIIa 75 Daclizumab 74 proteasome inhibitor 74 refractory chronic lymphocytic 73 Receives Orphan Drug Designation 73 anticancer compound 73 multi kinase inhibitor 73 sodium Injection 72 luteinizing hormone releasing 72 HCV protease inhibitor 72 Irinotecan 72 Azedra 72 PEG SN# 72 Nanobody 72 MKC# 71 TLR9 agonist 71 ALN TTR# 71 MEK inhibitor 71 KNS # 71 inhaled formulation 71 Guanilib 71 Cetrorelix 71 R sorafenib tablets 71 Initiates Phase II 71 Mipomersen 71 chemotherapy induced neutropenia 70 Octreotide 70 humanized monoclonal antibody 70 VALSTAR 70 Thiarabine 70 ALN TTR 70 Proxinium TM 70 humanized antibody 70 Epratuzumab 70 AEG# 70 phase IIb clinical 70 GLPG# 70 Voreloxin 70 Drug Candidate 70 DNA RNA Medicines 70 orally bioavailable 70 PEGylation technology 70 Eculizumab 70 Tesetaxel 70 TELINTRA 70 Cotara R 69 JAK1 69 MAXY G# 69 non alcoholic steatohepatitis 69 injectable formulation 69 Dapagliflozin 69 Microplasmin 69 inflammatory autoimmune diseases 69 cancer immunotherapies 69 Amplimexon 69 candidates bavituximab 69 ATL# [001] 69 REG1 69 Recombinant Human 69 Pivotal Phase III 69 forodesine 69 topical anti infective 69 thymalfasin 69 targeting CD# 69 humanized anti 69 Phase III Clinical Trial 69 mTOR inhibitor 69 Chemokine Therapeutics 69 Rebif ® 69 pseudobulbar affect PBA 69 BEMA TM Fentanyl 69 Aerosurf 69 vorinostat 68 poly ADP ribose polymerase 68 Locteron ® 68 Nexavar ® 68 MVA BN R 68 Kuvan R 68 Hepatitis C Virus HCV 68 Aliskiren 68 Excellarate 68 active cellular immunotherapy 68 epothilone 68 Metastatic Melanoma 68 Promedior 68 secondary hyperparathyroidism 68 polyclonal antibody 68 lung pancreatic 68 ThermoDox R 68 vascular disrupting agent 68 KRN# 68 therapeutic monoclonal antibodies 68 Lubiprostone 68 CCX# 68 photodynamic 68 PARP inhibitor 68 DAVANAT 68 superficial bladder cancer